omeprazole and c-peptide

omeprazole has been researched along with c-peptide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Koshelev, D; Kosheleva, L; Lagunas-Rangel, FA; Levit, S; Nedorubov, A; Rabinovitch, A; Schiöth, HB; Trukhan, V	1

Other Studies

1 other study(ies) available for omeprazole and c-peptide

Article	Year
Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice. Frontiers in endocrinology, 2022, Volume: 13 Topics: Animals; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; gamma-Aminobutyric Acid; Hypoglycemic Agents; Mice; Mice, Inbred NOD; Omeprazole; Proton Pump Inhibitors; Sitagliptin Phosphate	2022

Article

Year

Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice.

Frontiers in endocrinology, 2022, Volume: 13

Topics: Animals; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; gamma-Aminobutyric Acid; Hypoglycemic Agents; Mice; Mice, Inbred NOD; Omeprazole; Proton Pump Inhibitors; Sitagliptin Phosphate

2022